Why a Formal RFP Process Matters
Most healthcare organizations select lab partners the way they bought their last copier: a few phone calls, a competitive bid, and a signature. For commodity office equipment, that works. For STI testing — where turnaround time directly affects patient treatment, where reject rates can quietly inflate costs by 15-20%, and where a bad contract can lock you in for two years — it's expensive guesswork.
A well-constructed RFP forces vendors to commit their promises to paper before you sign anything. It creates an apples-to-apples comparison across multiple labs. And it gives your team a defensible rationale for the vendor you ultimately choose — critical when you're managing grant-funded budgets or 340B purchasing requirements.
The RFP is not bureaucracy. It's risk management. Clinics that skip it are the ones calling us after a bad lab contract goes sideways six months later.
Who Should Issue an RFP
Any clinic processing more than 150 STI specimens per month. Below that threshold, a standard vendor evaluation checklist is typically sufficient. Above it, the volume justifies a formal RFP with competitive bidding — the pricing leverage and contractual protections are worth the process overhead.
How to Structure Your Lab Partner RFP
A complete STI lab services RFP has seven sections. Each one has a specific job. Miss one, and vendors will fill the gap with favorable assumptions for their side.
State who you are, what you need, and what you're asking vendors to submit. This section is not just an introduction — it sets the scope boundary. Be specific:
- Organization type: FQHC, urgent care chain, hospital system, independent clinic
- Monthly specimen volume: Estimate by test type (CT/NG, TV, HIV, syphilis panels)
- Geographic service area: Clinic locations and specimen transport logistics
- EHR platform: Epic, Athena, eClinicalWorks, or other — dictates integration requirements
- Contract term sought: 12-month, 24-month, or pilot-first approach
- RFP submission deadline: Date, time, format (PDF vs. portal), and point of contact
This is the highest-stakes section. Require vendors to quote all-in cost per reportable result (CPRR) — not cost per test, not list price, not "contact us for pricing." The CPRR must include specimen transport, processing, reagents, quality control, and result delivery. Any fee not captured in the CPRR should be itemized separately.
- Volume-tiered pricing at your projected monthly volumes (100, 250, 500, 1,000+ specimens)
- Annual price escalation caps (e.g., CPI-indexed or fixed 2% max)
- Weekend and stat processing surcharges, if any
- Billing model: per test, per panel, per reportable result, or capitated
- Payment terms: Net 30, Net 45, or other
For benchmark pricing by volume tier, see our Cost Per Reportable Result guide.
Define your minimum acceptable TAT and require vendors to document their SLA commitments — not aspirational goals. Ask for:
- Contracted TAT guarantee with specificity: "X% of results within Y hours of specimen receipt"
- Separate TATs for routine vs. STAT orders
- How TAT is measured (receipt vs. accessioning vs. patient collection)
- Financial remedies for SLA misses: service credits, fee waivers, or termination triggers
- Historical 12-month TAT compliance data (not projected — actual)
- Escalation path when results are delayed beyond SLA window
Industry benchmarks: top-performing labs deliver 95%+ of NAAT results within 48 hours. See the full TAT benchmarks guide for what to demand by test type.
Specimen rejection is a hidden cost multiplier. Every rejected specimen means a patient callback, a second collection, staff time, and a delayed diagnosis. Require vendors to disclose:
- Current 12-month overall reject rate (industry standard: <3%)
- Reject rate breakdown by specimen type and rejection reason
- Policy on charging for rejected specimens (any charge for rejects is a non-starter)
- Redraw process: who initiates, who covers cost, what's the turnaround
- Collection training materials or onsite support offered
- CAP accreditation status and most recent proficiency testing results
Non-negotiable minimums that should be requirements, not nice-to-haves:
- CLIA certificate — current, verified, and applicable to the test menu you're sending
- Business Associate Agreement (BAA) — must be signed before any specimen or data is exchanged
- HIPAA compliance documentation — incident response plan, PHI access audit trail, breach notification timelines
- Encrypted result delivery — HL7 interface, HTTPS portal, or equivalent (not fax)
- Security audit summary — most recent HIPAA risk assessment or SOC 2 report
- Subcontracting disclosure — if specimens are sent to reference labs, all BAA coverage must extend to those labs
- State-specific reporting — confirmation that the lab handles mandatory STI case reporting in all states you operate in
Bad reporting is a silent productivity killer. Require vendors to specify exactly how results are delivered and what operational data you'll have access to:
- Result delivery method: HL7 interface to your EHR, portal, or other
- Real-time order tracking: specimen status from receipt through resulting
- Monthly performance dashboards: TAT distribution, reject rates, volume by test type
- Cost analytics: actual CPRR vs. contracted, broken down by panel
- SLA compliance reports: percentage of results meeting contracted TAT, monthly
- Data export format: CSV, HL7, FHIR, or custom — and within what timeframe upon request
- EHR integration setup timeline and implementation support
The exit clause deserves more attention than the pricing table. Ask vendors to clearly state:
- Contract term: Initial duration and renewal structure
- Termination notice: Days required for either party — 30-60 days is reasonable; 90+ days is a trap
- Early termination fee: Amount, trigger conditions, and whether it applies when the vendor misses SLAs
- Auto-renewal language: Opt-out window, renewal pricing, and notification requirements
- Volume minimums: Monthly specimen floor and penalties for falling below
- Data portability: Your right to export 100% of testing history in a usable format at any time, at no charge
- Pilot option: Whether a 30-90 day pilot with no volume commitment and no termination fee is available
Pro Tip: Include a Pilot Period Requirement
Make pilot availability a pass/fail criterion, not a nice-to-have. Any lab confident in their operations will accept a 60-90 day pilot with 200-400 specimens. Labs that refuse are protecting their real-world performance numbers from scrutiny. Send 200 specimens. Measure actual TAT, reject rates, and cost against what they quoted. If the numbers match, sign. If they don't, you just saved yourself a two-year contract.
Red Flags to Watch For in Vendor Responses
Experienced procurement teams know that what vendors don't answer is as revealing as what they do. Watch for these patterns in RFP responses:
Evasive or Incomplete Responses
- "Best effort" TAT language — Any response that doesn't include a specific percentage and hour commitment isn't a guarantee. It's a marketing statement
- No historical performance data — If they can't provide 12 months of actual TAT and reject rate numbers, ask yourself why. Good labs track this religiously
- Bundled pricing without CPRR breakdown — "All-inclusive" quotes that don't itemize costs are designed to hide margin and make comparison impossible
- Vague subcontracting language — "We may occasionally utilize reference lab partners" without naming them and confirming BAA coverage is a compliance risk
- Volume minimums buried in appendices — Penalties for falling below a monthly specimen floor buried 40 pages into a contract addendum
- Auto-renewal with narrow opt-out window — 12-month auto-renewal that requires cancellation notice 90 days before term end, in a certified letter, to a specific department. Common. Expensive to miss
- No data portability guarantee — "We can discuss data export upon contract termination" means they'll charge you for it or make it painful
- Incomplete compliance documentation — A CLIA certificate that expired last year, a BAA that doesn't cover their reference lab partners, or a security audit summary that's three years old
How to Evaluate and Score Vendor Responses
Score each vendor before getting on a call. If you wait until the sales demo, the narrative takes over. Use this weighted framework — rate each category 1 (poor) to 5 (excellent), multiply by weight, and total the scores. Maximum possible score: 500 points.
| Evaluation Criteria | Weight | What "5" Looks Like |
|---|---|---|
| CPRR Transparency & Competitiveness | 25% | All-in CPRR quoted, volume tiers provided, no hidden fees, competitive at your volume |
| TAT Commitment & SLA Rigor | 25% | Specific % + hours SLA, financial penalty clause, 12-month historical data provided |
| Quality & Reject Rate Standards | 20% | Documented reject rate <2%, no charge for rejects, CAP accreditation, collection training offered |
| Compliance & Security | 15% | Current CLIA cert, signed BAA, encrypted delivery, recent security audit, full subcontracting disclosure |
| Reporting & EHR Integration | 10% | Real-time tracking, monthly dashboards, direct EHR HL7 interface, easy data export |
| Contract Flexibility | 5% | Pilot option available, ≤60-day termination notice, no volume minimums, data portability guaranteed |
Any vendor scoring below 300 out of 500 should be cut before the first demo. Above 400 is a strong candidate. If two vendors score within 30 points of each other, the tiebreaker is always the pilot: whichever lab you're more willing to put 200 real specimens through first.
STI Lab Procurement Checklist
Use this before issuing your RFP to confirm you've covered every requirement, and again when evaluating responses to confirm every box is filled.
RFP Scope & Process
Pricing & Cost Requirements
Turnaround Time & Quality
Compliance & Documentation
Contract Terms
How ClearLane Fits Into This Process
If you're issuing an RFP because you're dissatisfied with a current lab partner — TAT creeping up, reject rates climbing, pricing that's harder to audit each quarter — the RFP process has real value. It forces discipline and creates a documented rationale for your choice.
But many clinics tell us the same thing: they know what they want from a lab partner, they just can't get a single vendor to deliver it all. Competitive CPRR pricing, guaranteed TAT, low reject rates, and clean EHR integration rarely coexist in a single lab relationship. That's the trade-off the market has historically forced on clinic operators.
ClearLane's routing model removes that trade-off. Instead of selecting one lab and hoping it performs, we route your specimens to the highest-performing lab at any given time — balancing capacity, TAT, and cost across a vetted network. You get a single vendor relationship with multi-lab performance. Transparent CPRR pricing. Contractual TAT guarantees. Real-time tracking from submission through result delivery.
For clinics that have gone through the RFP process and still ended up disappointed by single-vendor limitations, that's worth a conversation.
Ready to See What Your CPRR Could Be?
We'll put together a custom quote based on your test volume, mix, and geography — no commitment required. Or explore the related guides below to sharpen your evaluation criteria before issuing your RFP.